Scientists in France and Italy discover covid antibodies in pre-pandemic blood samples
RIO DE JANEIRO, BRAZIL – In a statement, Dr. Jay Bhattacharya, professor of medicine at Stanford, said antibodies to covid-19 were found in blood samples from September and November 2019 tested in France and Italy, refuting initial media reports that the virus originated from a wet market in Wuhan.
“The impact is huge,” Bhattacharya added, stressing that the virus was in the community long before the official launch date, “it was too late to stop the spread of the disease.”‘
Read also: Check out our coverage on curated alternative narratives
“We wasted two years of detention for nothing,” he charged.
Covid antibodies found in stored blood from Sept/Nov 2019 in European blood banks. The implications are enormous.
1. Long before the official start date, it was too late to stop the disease from spreading across the earth. We have wasted 2 years on lockdowns for nothing.
[1/4] https://t.co/HBNFVY8uTH— Jay Bhattacharya (@DrJBhattacharya) March 13, 2022
According to the scientist, both the Italian and French studies show that SARS-CoV-2 spread much earlier than expected through the “main international travel centers” in Europe. Positive samples were identified in asymptomatic individuals, according to the study.
“Although targeted surveillance and contact tracing did not detect local transmission in Europe before the second half of February, evidence is accumulating that SARS-CoV-2 was circulating in eastern France in early January 2020, and environmental studies suggest that the virus may have been present in northern Italy in December 2019,” the French researchers said.
Considering that the virus has been present in the European population since at least September 2019, Bhattacharya believes the April 2020 U.S. statistics indicating a three percent incidence of the virus among adults in Los Angeles County, California, “are not that surprising.”
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief